Alnylam Pharmaceuticals (ALNY) Total Debt (QoQ) (2016 - 2022)

Alnylam Pharmaceuticals (ALNY) Total Debt (QoQ) (2016 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 0.15%
Mar 31, 2022 0.15%
Dec 31, 2021 55.76%
Sep 30, 2021 0.15%
Jun 30, 2021 126.08%
Mar 31, 2021 0.16%
Jun 30, 2019 0.00%
Mar 31, 2019 0.00%
Dec 31, 2018 0.00%
Sep 30, 2018 0.00%
Jun 30, 2018 0.00%
Mar 31, 2018 0.00%
Dec 31, 2017 -80.00%
Sep 30, 2017 0.00%
Jun 30, 2017 0.00%
Mar 31, 2017 0.00%
Dec 31, 2016 0.00%
Sep 30, 2016 0.00%